Soleno Therapeutics (SLNO) Capital Expenditures (QoQ) (2015 - 2026)
Soleno Therapeutics (SLNO) Capital Expenditures (QoQ) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Soleno Therapeutics |
2.76 Bn |
2.51 Bn |
93.41 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-31.03% |
| Dec 31, 2025 |
5,700.00% |
| Sep 30, 2025 |
-92.86% |
| Dec 31, 2024 |
-95.81% |
| Sep 30, 2024 |
2,287.50% |
| Jun 30, 2024 |
-27.27% |
| Dec 31, 2021 |
160.00% |
| Mar 31, 2021 |
300.00% |
| Jun 30, 2019 |
-40.00% |
| Mar 31, 2019 |
400.00% |
| Dec 31, 2018 |
-60.00% |
| Dec 31, 2017 |
56,800.00% |
| Sep 30, 2017 |
200.00% |
| Jun 30, 2017 |
-125.00% |
| Mar 31, 2017 |
155.52% |
| Dec 31, 2016 |
-460.25% |
| Sep 30, 2016 |
100.00% |
| Jun 30, 2016 |
-94.74% |
| Mar 31, 2016 |
107.78% |
| Dec 31, 2015 |
-62.82% |
